I was wrong about Generics in orthopedics.

In a series of articles, I predicted that generic orthopedic implants—proven designs replicated at a lower cost—would capture at least 10% of the market this decade. 2017 article - Cheap orthopedic implants are coming to a neighborhood near you. 2016 article - The UK government and patients are benefiting from “low-risk” generic hip replacements2015 article - The time has come for Generic Orthopedic Implants2015 article - Zimmer says they are staying away from Robotics and Generic Implants2015 article - Stryker CEO is skeptical of the ‘repless’ generic sales model

I was wrong, and here's why...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top